Filter
45
Filtered Results: 45
Text search:
гепатит
С
Featured
Recommendations
8
New Publications
16
Language
Document type
No document type
19
Guidelines
16
Fact sheets
3
Manuals
2
Strategic & Response Plan
2
Studies & Reports
1
Resource Platforms
1
Videos
1
Countries / Regions
Russia
4
Ukraine
2
Armenia
2
Global
2
Eastern Europe
2
Tajikistan
1
Albania
1
Africa
1
Latin America and the Carribbean
1
South–East Asia Region
1
Argentina
1
South Africa
1
Moldova
1
Authors & Publishers
Publication Years
Category
Hepatitis
41
Pediatrics
8
Gynaecology & Obstetrics
3
Paediatrics
2
Virology
2
Guidelines
2
HIV & STI
2
Communicable Diseases
1
Countries
1
Policies
1
Communicable Diseases
1
Maternal Health
1
TB
1
Toolboxes
Hepatitis
8
Paediatrics
3
Opportunistic Infections
2
Women
2
Prevention of mother-to-child transmission (PMTCT)
2
Eastern Europe & Central Asia
2
Drugs
1
TB & Drug Abuse
1
Adults
1
Ukraine
1
Prevention Guidelines
1
Policies
1
Transgender People
1
Men who have sex with men (MSM)
1
People who injecting Drugs
1
IEC Materials
1
HIV / AIDS
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Information, Resources & Websites
1
Armenia
1
Drug resistant TB
1
Co-Morbidities (except TB)
1
Substance Use Disorders & Addiction
1
HIV / AIDS
1
Clinical Guidelines
1
HIV in Key Populations
1
Prisoners
1
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Краткое содержание лекций семинара. На семинаре обсуждались ключевые проблемы в регионе, связанные с заболеваемостью ВИЧ, туберкулезом и гепатитом у людей, употре...
Презентация на тему значимости скрининга больных с лекарственно-устойчивым туберкулезом на гепатит С. Как лучше всего лечить этих пациентов от гепатита С.
В основе настоящих руководящих принципов лежит структура организации мероприятий в соответствии с тремя задачами:
• создание и укрепление механизмов комплексно...
ПЛАНИРОВАНИЕ И МОНИТОРИНГ ПРОГРЕССА НА ПУТИ К ЭЛИМИНАЦИИ
ПЛАНИРОВАНИЕ И МОНИТОРИНГ ПРОГРЕССА НА ПУТИ К ЭЛИМИНАЦИИ
В мае 2016 г. Всемирная ассамблея здравоохранения приняла первую Глобальную стратегию сектора здравоохранения (ГССЗ) по проблеме вирусных гепатитов. В ней б...
Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several
regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting
of anonymized, patient-level data of acute hepatitis of unknown aetiology.
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and...
WHO’s Dr Philippa Easterbrook gives a situation update on the recent hepatitis outbreak affecting children including possible causes and steps parents, caregivers and countries should take.
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Malgré les progrès récents vers la mise au point d’un traitement hautement efficace et abordable contre le virus de l’hépatite C, beaucoup de personnes infectées par ce virus ne connaissent pas leur statut. L’Organisation mondiale de la Santé (OMS) estime qu’en 2019, 58 millions ...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
L’objectif des lignes directrices 2024 est de fournir des recommandations actualisées et fondées sur
des données probantes sur les principaux sujets prioritaires. Ceux-ci concernent notamment les critères élargis et simplifiés de mise sous traitement pour les adultes, mais aussi désormais ...
